Category: Current Studies

Zambart is leading the operational research task of the USAID-sponsored Eradicate TB project (ETB). From 2017-2021, ETB will work in partnership with the National Tuberculosis Program (NTP) to halve TB-related mortality in the 6 northern provinces by the year 2022.…

YATHU YATHU: a trial in the pipeline! Yathu Yathu seeks to address the question: do community based peer led interventions increase knowledge of HIV status and coverage of sexual and reproductive health (SRH) services among adolescents and young people in…

What is the STAR Study? The acronym STAR is for Self-testing AfRica. HIV Self Testing (HIVST) is a new phenomenon in Africa and has the potential to reach the unreached population who are not aware of their status. Despite this…

Zambart is one of the study sites for a Phase IIb trial of a new TB vaccine. The trial is being conducted by Aeras and GlaxoSmithKline Vaccines, S.A. (GSK) and is a double-blind randomised, placebo controlled study. (Clinical Trail.gov Identifier:…

Please click here for news on the TREAT study.

HIV infection remains at a very high level in Zambia. The national HIV prevalence rate among adults 15-49 years currently stands at 14.3% (2007 ZDHS). Although this represents a slight decrease from the 15.6% prevalence observed in the 2001-02 ZDHS,…